ERUPT Trial: Urethral scarring after radiation treatment for prostate cancer

This study will aim to measure the incidence of urethral strictures that develop after external beam radiotherapy for prostate cancer. Who is it for? You may be eligible for this study if you are an adult with prostate cancer who is undergoing radiotherapy treatment at Icon Cancer Centre Toowoomba QLD, Australia. Study details All participants will need to do is attend an assessment session 6 weeks following the end of radiation therapy treatment and then every 6 months for 5 years. This assessment will involve surveys and a urine flow test that is performed in the clinic. This flow test involves urinating into a flow meter to measure urine flow. It is non-invasive and only takes five to ten minutes to complete. It is hoped that the results from this study will help guide future radiotherapy treatment regimes and aid in the early detection of urethral strictures post-radiotherapy. Thus, leading to a reduction in invasive procedures and decreased overall morbidity. It will also fill the gap in the literature as there are currently no prospective trials on this topic.